Holen Sie sich die Stockscreener-App
1.66
26.72%
0.35
Handel nachbörslich:
1.65
-0.01
-0.60%
Schlusskurs vom Vortag:
$1.31
Offen:
$1.35
24-Stunden-Volumen:
2.86M
Relative Volume:
2.30
Marktkapitalisierung:
$20.42M
Einnahmen:
$22.06M
Nettoeinkommen (Verlust:
$-30.94M
KGV:
-0.7411
EPS:
-2.24
Netto-Cashflow:
$-26.70M
1W Leistung:
+9.21%
1M Leistung:
-28.14%
6M Leistung:
-23.15%
1J Leistung:
-73.05%
1-Tages-Spanne:
$1.25
$1.70
1-Wochen-Bereich:
$1.21
$1.70
52-Wochen-Spanne:
$1.0909
$7.50
Casi Pharmaceuticals Inc Stock (CASI) Company Profile
Firmenname
Casi Pharmaceuticals Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie CASI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CASI
Casi Pharmaceuticals Inc
|
1.66 | 20.30M | 22.06M | -30.94M | -26.70M | -2.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Casi Pharmaceuticals Inc Stock (CASI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-18 | Eingeleitet | BTIG Research | Buy |
| 2021-04-26 | Eingeleitet | Mizuho | Buy |
| 2020-10-23 | Eingeleitet | Oppenheimer | Outperform |
| 2016-09-22 | Eingeleitet | Maxim Group | Buy |
| 2015-10-29 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-06-23 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Casi Pharmaceuticals Inc Aktie (CASI) Neueste Nachrichten
Can CASI Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Growth Summary & High Conviction Buy Zone Alerts - newser.com
Little Excitement Around CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Revenues As Shares Take 43% Pounding - simplywall.st
What analysts say about CASI Pharmaceuticals Inc stockHigh Beta Stocks & Small Investment Capital Tips - earlytimes.in
Does CASI Pharmaceuticals Inc. qualify in momentum factor screening2025 Market Sentiment & Fast Moving Market Watchlists - newser.com
Intraday pattern recognizer results for CASI Pharmaceuticals Inc.Weekly Investment Recap & Expert Curated Trade Ideas - newser.com
Can CASI Pharmaceuticals Inc. hit a new high this monthPortfolio Profit Report & Verified Swing Trading Watchlists - newser.com
Why CASI Pharmaceuticals Inc. stock remains undervaluedWeekly Trend Recap & Comprehensive Market Scan Insights - newser.com
Why CASI Pharmaceuticals Inc. is moving today2025 Growth vs Value & Fast Exit Strategy with Risk Control - newser.com
Will CASI Pharmaceuticals Inc. benefit from macro trendsQuarterly Performance Summary & Fast Moving Trade Plans - newser.com
Is CASI Pharmaceuticals Inc. showing signs of accumulation2025 Market Outlook & Daily Volume Surge Trade Alerts - newser.com
How to interpret RSI for CASI Pharmaceuticals Inc. stockJuly 2025 Market Mood & Reliable Entry Point Alerts - newser.com
Order flow analysis tools used on CASI Pharmaceuticals Inc.July 2025 Selloffs & Verified Trade Idea Suggestions - newser.com
Will CASI Pharmaceuticals Inc. stock maintain dividend yield2025 Winners & Losers & Safe Entry Momentum Tips - newser.com
Why Hedge Funds Are Buying Amerise Biosciences Limited in YEARRisk Mitigation Techniques & Small Budget Trading Tips - earlytimes.in
Trend analysis for CASI Pharmaceuticals Inc. this weekJuly 2025 Snapshot & Fast Moving Stock Watchlists - newser.com
CASI Pharmaceuticals Strengthens Board with Industry Veteran James Huang - TipRanks
James Huang to join CASI Pharmaceuticals board as independent director - Investing.com
James Huang to join CASI Pharmaceuticals board as independent director By Investing.com - Investing.com Canada
CASI Pharmaceuticals Appoints James Huang to Board of Directors - ACCESS Newswire
Finanzdaten der Casi Pharmaceuticals Inc-Aktie (CASI)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
1.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):